230 related articles for article (PubMed ID: 30929105)
1. Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes.
Schcolnik-Cabrera A; Oldak B; Juárez M; Cruz-Rivera M; Flisser A; Mendlovic F
Apoptosis; 2019 Apr; 24(3-4):245-255. PubMed ID: 30929105
[TBL] [Abstract][Full Text] [Related]
2. Biphasic Increases of Cell Surface Calreticulin Following Treatment with Mitoxantrone.
Azuma Y; Suzuki K; Higai K; Matsumoto K; Tada S
Biol Pharm Bull; 2020 Oct; 43(10):1595-1599. PubMed ID: 32727970
[TBL] [Abstract][Full Text] [Related]
3. ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin.
Obeid M
J Immunol; 2008 Aug; 181(4):2533-43. PubMed ID: 18684944
[TBL] [Abstract][Full Text] [Related]
4. Viral subversion of immunogenic cell death.
Kepp O; Senovilla L; Galluzzi L; Panaretakis T; Tesniere A; Schlemmer F; Madeo F; Zitvogel L; Kroemer G
Cell Cycle; 2009 Mar; 8(6):860-9. PubMed ID: 19221507
[TBL] [Abstract][Full Text] [Related]
5. Wogonin induced calreticulin/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK/AKT dependent manner.
Yang Y; Li XJ; Chen Z; Zhu XX; Wang J; Zhang LB; Qiang L; Ma YJ; Li ZY; Guo QL; You QD
PLoS One; 2012; 7(12):e50811. PubMed ID: 23251389
[TBL] [Abstract][Full Text] [Related]
6. Endoplasmic reticulum calcium depletion impacts chaperone secretion, innate immunity, and phagocytic uptake of cells.
Peters LR; Raghavan M
J Immunol; 2011 Jul; 187(2):919-31. PubMed ID: 21670312
[TBL] [Abstract][Full Text] [Related]
7. The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells.
Vera CA; Oróstica L; Gabler F; Ferreira A; Selman A; Vega M; Romero CA
Int J Oncol; 2017 Apr; 50(4):1261-1270. PubMed ID: 28260038
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppression by Mutated Calreticulin Released from Malignant Cells.
Liu P; Zhao L; Loos F; Marty C; Xie W; Martins I; Lachkar S; Qu B; Waeckel-Énée E; Plo I; Vainchenker W; Perez F; Rodriguez D; López-Otin C; van Endert P; Zitvogel L; Kepp O; Kroemer G
Mol Cell; 2020 Feb; 77(4):748-760.e9. PubMed ID: 31785928
[TBL] [Abstract][Full Text] [Related]
9. Ecto-calreticulin in immunogenic chemotherapy.
Obeid M; Tesniere A; Panaretakis T; Tufi R; Joza N; van Endert P; Ghiringhelli F; Apetoh L; Chaput N; Flament C; Ullrich E; de Botton S; Zitvogel L; Kroemer G
Immunol Rev; 2007 Dec; 220():22-34. PubMed ID: 17979837
[TBL] [Abstract][Full Text] [Related]
10. Emerging Roles of Calreticulin in Cancer: Implications for Therapy.
Venkateswaran K; Verma A; Bhatt AN; Shrivastava A; Manda K; Raj HG; Prasad A; Len C; Parmar VS; Dwarakanath BS
Curr Protein Pept Sci; 2018 Feb; 19(4):344-357. PubMed ID: 28079009
[TBL] [Abstract][Full Text] [Related]
11. Calreticulin as a marker and therapeutic target for cancer.
Zhang M; Xiao J; Liu J; Bai X; Zeng X; Zhang Z; Liu F
Clin Exp Med; 2023 Sep; 23(5):1393-1404. PubMed ID: 36335525
[TBL] [Abstract][Full Text] [Related]
12. Whole-cell vaccine coated with recombinant calreticulin enhances activation of dendritic cells and induces tumour-specific immune responses.
Wu H; Han Y; Qin Y; Cao C; Xia Y; Liu C; Wang Y
Oncol Rep; 2013 Feb; 29(2):529-34. PubMed ID: 23166014
[TBL] [Abstract][Full Text] [Related]
13. Calreticulin: non-endoplasmic reticulum functions in physiology and disease.
Gold LI; Eggleton P; Sweetwyne MT; Van Duyn LB; Greives MR; Naylor SM; Michalak M; Murphy-Ullrich JE
FASEB J; 2010 Mar; 24(3):665-83. PubMed ID: 19940256
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles in phagocytosis of the early and late increases of cell surface calreticulin induced by oxaliplatin.
Matsusaka K; Azuma Y; Kaga Y; Uchida S; Takebayashi Y; Tsuyama T; Tada S
Biochem Biophys Rep; 2022 Mar; 29():101222. PubMed ID: 35146135
[TBL] [Abstract][Full Text] [Related]
15. Relative contribution of c1q and apoptotic cell-surface calreticulin to macrophage phagocytosis.
Verneret M; Tacnet-Delorme P; Osman R; Awad R; Grichine A; Kleman JP; Frachet P
J Innate Immun; 2014; 6(4):426-34. PubMed ID: 24557008
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic cell death and DAMPs in cancer therapy.
Krysko DV; Garg AD; Kaczmarek A; Krysko O; Agostinis P; Vandenabeele P
Nat Rev Cancer; 2012 Dec; 12(12):860-75. PubMed ID: 23151605
[TBL] [Abstract][Full Text] [Related]
17. Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin.
Tufi R; Panaretakis T; Bianchi K; Criollo A; Fazi B; Di Sano F; Tesniere A; Kepp O; Paterlini-Brechot P; Zitvogel L; Piacentini M; Szabadkai G; Kroemer G
Cell Death Differ; 2008 Feb; 15(2):274-82. PubMed ID: 18034188
[TBL] [Abstract][Full Text] [Related]
18. Calreticulin-Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients.
Kielbik M; Szulc-Kielbik I; Klink M
Cells; 2021 Jan; 10(1):. PubMed ID: 33440842
[TBL] [Abstract][Full Text] [Related]
19. Calreticulin exposure dictates the immunogenicity of cancer cell death.
Obeid M; Tesniere A; Ghiringhelli F; Fimia GM; Apetoh L; Perfettini JL; Castedo M; Mignot G; Panaretakis T; Casares N; Métivier D; Larochette N; van Endert P; Ciccosanti F; Piacentini M; Zitvogel L; Kroemer G
Nat Med; 2007 Jan; 13(1):54-61. PubMed ID: 17187072
[TBL] [Abstract][Full Text] [Related]
20. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
Garg AD; Elsen S; Krysko DV; Vandenabeele P; de Witte P; Agostinis P
Oncotarget; 2015 Sep; 6(29):26841-60. PubMed ID: 26314964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
